Zhongyu Liu1, Xiuli Li2, Weiping Li1, Yizhuo Yang1, Ye Tao3, Yuanqing Yao4. 1. Department of Obstetrics and Gynecology, PLA General Hospital, Beijing, China. 2. Department of Obstetrics and Gynecology, Hainan Branch of PLA General Hospital, Sanya, China. 3. Department of Ophthalmology, PLA General Hospital, Beijing, China. 4. Department of Obstetrics and Gynecology, PLA General Hospital, Beijing, China. Electronic address: yqyao301hp@163.com.
Abstract
OBJECTIVE: To evaluate the feasibility and safety of robotic nerve-sparing radical hysterectomy for locally advanced cervical cancer (LACC). METHODS: In a retrospective study, data were analyzed for patients treated for cervical cancer at a center in Beijing, China, between December 2011 and September 2013. Patients were subdivided into those with early-stage disease (FIGO stage IA2-IB1) who were treated by robotic surgery (group 1), and those with LACC (stage IB2-IIB) who were treated by robotic surgery after neoadjuvant chemotherapy (NACT; group 2). Therapeutic outcomes and complications were compared. RESULTS: Group 1 included 32 patients and group 2 included 22 patients. Two patients in group 2 did not respond to NACT and did not undergo surgery. The operative outcomes and incidences of complications did not differ significantly between the two groups (P>0.05 for all). There were no differences in nodal yield, lengths of parametrium removed, or vaginal cuff length (P>0.05 for all). During a mean follow-up of 26months, no patient experienced recurrence. CONCLUSION: Robotic nerve-sparing radical hysterectomy was found to be feasible and safe for LACC after NACT. A larger case series with longer follow-up data is needed to justify its widespread application.
OBJECTIVE: To evaluate the feasibility and safety of robotic nerve-sparing radical hysterectomy for locally advanced cervical cancer (LACC). METHODS: In a retrospective study, data were analyzed for patients treated for cervical cancer at a center in Beijing, China, between December 2011 and September 2013. Patients were subdivided into those with early-stage disease (FIGO stage IA2-IB1) who were treated by robotic surgery (group 1), and those with LACC (stage IB2-IIB) who were treated by robotic surgery after neoadjuvant chemotherapy (NACT; group 2). Therapeutic outcomes and complications were compared. RESULTS: Group 1 included 32 patients and group 2 included 22 patients. Two patients in group 2 did not respond to NACT and did not undergo surgery. The operative outcomes and incidences of complications did not differ significantly between the two groups (P>0.05 for all). There were no differences in nodal yield, lengths of parametrium removed, or vaginal cuff length (P>0.05 for all). During a mean follow-up of 26months, no patient experienced recurrence. CONCLUSION: Robotic nerve-sparing radical hysterectomy was found to be feasible and safe for LACC after NACT. A larger case series with longer follow-up data is needed to justify its widespread application.
Authors: Yanyan Zhao; Zhongyu Liu; Ling Yu; Sai Liu; Hong Yan; Yan Zhang; Yuanqing Yao Journal: Wideochir Inne Tech Maloinwazyjne Date: 2019-10-23 Impact factor: 1.195